Curcumin-loaded nanocarriers for dermatological applications: current advances and biomedical implications
DOI:
https://doi.org/10.17179/excli2026-9317Keywords:
topical drug delivery, nanoparticles, anti-inflammatory, antioxidant, antibacterial, nanocurcuminAbstract
Topical drug delivery routes have long served as a primary therapeutic approach for treating various skin disorders. However, conventional formulations, like creams, ointments, and gels, have a number of drawbacks, such as systemic toxicity, short duration of action, low skin permeability, and drug instability. Through the advancement of innovative delivery carriers such solid lipid nanoparticles, nanostructured lipid carrier system, nanoemulsions, & transdermal patches, recent developments in nanotechnology have completely changed topical delivery. These technologies improve skin penetration, provide regulated release, and increase medication absorption. Furthermore, because of their excellent therapeutic results, tailored particle size, and high entrapment effectiveness, formulations such as cubosomes, nanogels, and microsponges are being investigated. The significant expansion of topical delivery platforms, particularly hydrogel-based and nanoemulgel formulations, is highlighted by biostatistics from 2023-2024. Novel delivery systems have shown considerable effectiveness in treating dermatological disorders such atopic dermatitis, psoriasis, and eczema in clinical trials. Concurrently, the anti-inflammatory, antioxidant, and antibacterial qualities of botanical substances such as curcumin, bolstered by improved delivery through liposomal and nanocurcumin formulations, have demonstrated encouraging outcomes. This review explored the advancement of nanotechnology-enabled topical and transdermal delivery platforms, their clinical use, technical developments, and the growing use of natural bioactives like curcumin in dermatological treatment are all thoroughly covered in this study. The combined results highlight how crucial novel formulations and delivery methods are to resolving issues with the skin barrier and enhancing patient outcomes.
Downloads
Published
How to Cite
License
Copyright (c) 2026 Tanuj Sharma, Jagdeep Singh, Vishal Sharma, Diksha Sharma, Rina Das, Dinesh Kumar Mehta, Isha Chawla, Sonia Yadav, Shivani Chopra, Hitesh Chopra, Jai Bharti Sharma

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
- The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
- The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
- Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
- The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).
